Skip to main content
. 2009 Mar 30;53(6):2483–2491. doi: 10.1128/AAC.00428-08

TABLE 2.

Overview of the MFs, mutation rates, and levels of resistance of the GO mutants

Mutant Doubling time (min) Mutation rate Mean MF in response to:
MIC (mg/liter) by Etesta (size of resistant mutant subpopulationb)
Rifampin (300 μg/ml) Streptomycin (500 μg/ml) PIP CAZ TOB CIP ATM
PAO1 26 ± 0.6 6.75E-09 1.81E-8 8.48E-10 2 (+) 2 1.5 0.19 1.5
PAO1/pUCP26 1.37E-8 5.38E-10
PAO1ΔmutY::Gm 25.7 ± 1.7 3.85E-08 1.36E-7 3.51E-9 2 (++) 1.5 (++) 1.5 (+) 0.19 (+) 1 (+)
PAO1ΔmutY::Gm/pLM100 6.36E-8 1.29E-9
PAO1ΔmutT::Gm 27.7 ± 1.8 1.28E-07 5.07E-7 1.18E-7 2 (+++) 2 (+++) 1.5 (++) 0.25 (++) 1.5 (++)
PAO1ΔmutT::Gm/pLM101 3.91E-8 1.69E-9
PAO1ΔmutM::Gm 27.3 ± 1 6.38E-09 2.78E-8 1.69E-9 2 (++) 1.5 (+) 1.5 0.19 1.5
PAO1ΔmutM::Gm/pLM102 2.53E-8 3.72E-10
a

PIP, piperacillin; CAZ, ceftazidime; TOB, tobramycin; CIP, ciprofloxacin; ATM, aztreonam.

b

The numbers of resistant mutant colonies in the inhibition zone are as follows: +, <10; ++, 10 to 100; +++, >100 (35).